Viridian Therapeutics Inc (VRDN)

Currency in USD
17.28
-0.21(-1.20%)
Real-time Data·

VRDN Earnings

Latest Release
May 06, 2025
EPS / Forecast
-0.87 / -0.98
Revenue / Forecast
70.00K / 52.09K
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-1--/50.92K----Free Sign Up
03/2025-0.87/-0.9870K/52.09K+11.22%+34.38%Free Sign Up
12/2024-0.81/-1.0372K/50.92K+21.36%+41.4%Free Sign Up
09/2024-1.15/-1.0686K/91K-8.49%-5.49%Free Sign Up
06/2024-1.02/-0.8772K/78.15K-17.24%-7.87%Free Sign Up
03/2024-0.79/-1.0972K/138.1K+27.52%-47.86%Free Sign Up
12/2023-1.35/-1.3572K/72K0%0%Free Sign Up
09/2023-1.09/-1.2572K/141.08K+12.8%-48.97%Free Sign Up
06/2023-1.27/-1.2670K/254K-0.79%-72.44%Free Sign Up
03/2023-1.61/-1.01100K/131.38K-59.41%-23.88%Free Sign Up

All numbers in USD

Viridian Therapeutics Inc Earnings Call Summary for Q1/2024

  • Phase 3 trial for VRDN-001 in active TED completed enrollment; top-line results expected September 2024; BLA filing planned for H2 2025
  • Subcutaneous VRDN-003 program to start pivotal trials mid-year after positive FDA Type C meeting
  • IND filing for VRDN-006 by year-end; non-human primate data for VRDN-008 due H2 2024
  • $613 million cash position provides runway into H2 2026; company on track with clinical timelines and regulatory milestones
  • CEO highlights underpenetrated TED market potential; subcutaneous delivery method seen as game-changing for patient care
Last Updated: 09/05/2024, 18:28
Read Full Transcript

FAQ

What Is Viridian Therapeutics's Earnings Per Share (TTM)?

The Viridian Therapeutics EPS (TTM) is -3.33.

When Is The Next Viridian Therapeutics Earnings Date?

Viridian Therapeutics will release its next earnings report on 05 Aug 2025.

What Is Viridian Therapeutics’s Revenue Forecasts For Upcoming Quarters?

Viridian Therapeutics’s revenue forecast is 50.92K.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.